News
Chardan Capital Maintains Buy on Oculis Holding, Maintains $30 Price Target
19 Mar 24
News, Price Target, Analyst Ratings
Baird Maintains Outperform on Oculis Holding, Lowers Price Target to $35
19 Mar 24
News, Price Target, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Oculis Holding, Maintains $29 Price Target
29 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Oculis Updates On Late-Stage Clinical Trials At R&D Day
28 Feb 24
News
Press releases
Oculis to Participate at Upcoming April Investor Conferences
4 Apr 24
News, Press Releases
Oculis Reports Q4 and Full Year 2023 Financial Results and Update on Company Progress
18 Mar 24
Earnings, Press Releases
Oculis Provides Updates at R&D Day on Late-Stage Clinical Trials and Announces Key Leadership Appointments
28 Feb 24
News, Management, Press Releases
Oculis to Present at Upcoming February Investor Conferences
29 Jan 24
News, Press Releases